Author

Xueshuai Ye

Hebei University of EngineeringORCID 0000-0003-4874-874XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Dejing Kong· 1 shared Fei Liu· 1 shared Jiabao Song· 1 shared Jingtao Ma· 1 shared Jun Wang· 1 shared Lianmei ZhaoiD· 1 shared Na Zhang· 1 shared Qichen YuaniD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Dejing Kong

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 17, 2026

Cardiomyocytes upregulated PD-L1 expression to alleviate cardiac injury induced by irradiation combined with anti-PD-1 antibody: an in vitro and in vivo study

Ye Zhou, Yajing Wu, Na Zhang…·Jun Wang

This study shows irradiation increases PD-L1 in cardiomyocytes, which may protect against cardiac injury by limiting inflammation and CD8 T-cell activity in mice.

DOI 10.64898/2026.09.14.751375

mouseexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintMar 21, 2024

Engineering One-Signal Activated TILs with CD3ζ-CD28 Chimeras Optimizes the Antitumor Efficacy of TIL-Based Immunotherapy

Yongqiang Wu, Xueshuai Ye, Yufeng Zhu…·Lianmei Zhao

This paper engineers one-signal-activated TILs with CD3ζ-CD28 chimeras to enhance antitumor efficacy in immunotherapy.

DOI 10.1101/2024.03.21.586203

humanCITE-seq

𝕏 PostBluesky